Interchange Capital Partners LLC Has $78,000 Holdings in UnitedHealth Group Incorporated $UNH

Interchange Capital Partners LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 94.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 249 shares of the healthcare conglomerate’s stock after selling 4,172 shares during the quarter. Interchange Capital Partners LLC’s holdings in UnitedHealth Group were worth $78,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the stock. Mutual Advisors LLC increased its stake in UnitedHealth Group by 26.8% in the 2nd quarter. Mutual Advisors LLC now owns 21,220 shares of the healthcare conglomerate’s stock valued at $6,620,000 after buying an additional 4,488 shares during the period. Harbour Investments Inc. increased its stake in UnitedHealth Group by 150.6% in the 2nd quarter. Harbour Investments Inc. now owns 15,703 shares of the healthcare conglomerate’s stock valued at $4,899,000 after buying an additional 9,438 shares during the period. Mitchell Mcleod Pugh & Williams Inc. increased its stake in UnitedHealth Group by 5.7% in the 2nd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 6,739 shares of the healthcare conglomerate’s stock valued at $2,102,000 after buying an additional 366 shares during the period. Cypress Wealth Services LLC increased its stake in shares of UnitedHealth Group by 12.5% during the 2nd quarter. Cypress Wealth Services LLC now owns 1,578 shares of the healthcare conglomerate’s stock worth $492,000 after purchasing an additional 175 shares during the last quarter. Finally, Hamilton Point Investment Advisors LLC increased its stake in shares of UnitedHealth Group by 4.2% during the 2nd quarter. Hamilton Point Investment Advisors LLC now owns 1,671 shares of the healthcare conglomerate’s stock worth $521,000 after purchasing an additional 67 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently commented on UNH. KeyCorp increased their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Finally, Robert W. Baird reaffirmed an “underperform” rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Seventeen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Hold” and a consensus target price of $384.09.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $359.70 on Wednesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The firm has a fifty day moving average price of $322.74 and a two-hundred day moving average price of $347.08. The company has a market cap of $325.77 billion, a PE ratio of 15.58, a price-to-earnings-growth ratio of 2.32 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period last year, the company earned $6.80 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.